From: Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients
Response to Her-2
No. of patients
Percentage dead
p value
CD4 response
Yes
33
36 %
0.1
No
4
0 %
CD8 response
18
13 %
0.03
19
47 %
CD4 and CD8 response
14
21 %
0.2
23
39 %